NCT00170612View on ClinicalTrials.gov

Pneumococcal Vaccination of Fiji Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

August 31, 2008

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Pneumovax 23

23-valent PPS, 25 micrograms/serotype

BIOLOGICAL

Prevnar

7-valent PCV, 2 micrograms/serotype, except serotype 6B which is 4 micrograms/serotype

Trial Locations (1)

Unknown

Colonial War Memorial Hospital, Suva

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Melbourne

OTHER

NCT00170612 - Pneumococcal Vaccination of Fiji Infants | Biotech Hunter | Biotech Hunter